Log in or Sign up for Free to view tailored content for your specialty!
Gastrointestinal Cancer News
VIDEO: No survival benefit of resecting asymptomatic primary tumor
In this video Michael Cecchini, MD discussed study presented at ASCO that "puts to rest" whether asymptomatic primary tumors in patients with metastatic colorectal cancer should be resected.
Cancer clinical trials recover from substantial disruption during COVID-19 pandemic
Oncology clinical trials appeared to recover from declines in enrollment and activation during the early phase of the COVID-19 pandemic, according to a study of data from two large academic centers published in Annals of Oncology.
Log in or Sign up for Free to view tailored content for your specialty!
Marital status may predict long-term survival in early-stage gastric cancer
Being married may increase the chances of long-term survival among patients with early-stage gastric cancer, according to research published in Journal of Investigative Medicine.
Atezolizumab plus FLOT regimen beneficial for resectable esophagogastric adenocarcinoma
The effects of atezolizumab combined with a chemotherapy regimen were beneficial in terms of pathologic outcome compared with the chemotherapy regimen alone for patients with resectable esophagogastric adenocarcinoma.
No difference in HCC risk between tenofovir, entecavir for chronic HBV infection
There was no clinically meaningful difference in the risk for hepatocellular carcinoma between patients taking tenofovir vs. entecavir to treat chronic hepatitis B virus infection, according to study results published in JAMA Network Open.
Biden names three cancer panel members, Cancer Cabinet outlines priorities
President Joe Biden has appointed Elizabeth M. Jaffee, MD; Mitchel Berger, MD; and Carol L. Brown, MD, FACOG, FACS, to the President’s Cancer Panel, the White House announced in a press release.
Disparities observed in receipt of cancer treatment during COVID-19 pandemic
Certain racial and ethnic minority patients with cancer experienced worse treatment delays and adverse social and economic effects due to the COVID-19 pandemic than white patients, according to study results published in JAMA Network Open.
Neoadjuvant chemotherapy regimen extends survival in pancreatic cancer
Neoadjuvant modified FOLFIRINOX alone vs. with hypofractionated radiotherapy demonstrated favorable OS among patients with borderline resectable pancreatic cancer, according to results of a phase 2 trial published in JAMA Oncology.
Chemotherapy-immunotherapy combination shows efficacy in esophagogastric cancer subset
A combination of nivolumab, trastuzumab and chemotherapy prolonged PFS and OS among patients with previously untreated, metastatic ERBB2-positive esophagogastric cancer, according to study results published in JAMA Oncology.
Medical financial hardship linked to increased mortality risk among cancer survivors
Long-term medical financial hardship after active cancer treatment has become an important topic in survivorship and has been evaluated in several studies.
-
Headline News
NIH finds neuroscience director engaged in research misconduct
September 26, 20241 min read -
Headline News
Q&A: Phone app uses AI technology to personalize allergy forecasts
September 25, 20243 min read -
Headline News
FDA grants fast track designation to brepocitinib for noninfectious uveitis
September 25, 20241 min read
-
Headline News
NIH finds neuroscience director engaged in research misconduct
September 26, 20241 min read -
Headline News
Q&A: Phone app uses AI technology to personalize allergy forecasts
September 25, 20243 min read -
Headline News
FDA grants fast track designation to brepocitinib for noninfectious uveitis
September 25, 20241 min read